Sigma Planning Corp Purchases 300 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Sigma Planning Corp lifted its holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 2.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 12,405 shares of the biotechnology company’s stock after purchasing an additional 300 shares during the period. Sigma Planning Corp’s holdings in Sarepta Therapeutics […]

Related Keywords

Blackrock ,New Zealand General ,New Zealand ,Canada ,Wellington ,Douglass Ingram ,Richard Barry ,Nasdaq ,Sigma Planning Corp ,Cantor Fitzgerald ,Citigroup ,York Mellon Corp ,Royal Bank ,Sarepta Therapeutics Inc ,Blackrock Inc ,Geode Capital Management ,Securities Exchange Commission ,Wellington Management Group ,Barclays ,Sarepta Therapeutics ,Free Report ,Planning Corp ,Management Group ,New York Mellon Corp ,Street Corp ,Capital Management ,Exchange Commission ,Director Richard Barry ,Get Free Report ,Sarepta Therapeutics Daily ,Nasdaq Srpt ,Srpt ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,